Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Evaluation of Safety and Tolerance of Commercially Available Naltrexone Administered Daily - Assessment for CBRN Operations

NCT03879460 is registered in ClinicalTrials.gov with Timothy Smith as lead sponsor.

NCT NCT03879460
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03879460 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Evaluation of Safety and Tolerance of Commercially Available Naltrexone Administered Daily - Assessment for CBRN Operations
Lead sponsor
Timothy Smith
Phase
Phase 1
Overall status
Completed
Start date
March 18, 2019
Completion date
March 31, 2019
Enrollment
15 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

opioid intoxication